+33(0)1 42 54 60 64 | contact@welcomeurope.com

EU4H – Develop early warning features and guidance in the area of pricing through the EURIPID database, based on competition cases – 2022

EU4H - Develop early warning features and guidance in the area of pricing through the EURIPID database, based on competition cases, aiming at developing early warning mechanisms and guidance in the area of pricingthrough the EURIPID database, based on lessons from competition cases, in particular on excessive pricing.

2022-05-24
300,000 euro
Close

Appeal framework

Institution European Commission
Sectors Finance Health
Beneficiaries Local Authority & Affiliated Entity
Regions Developing countries, European Economic Area, European Union
Details
  • EU Member States (including overseas countries and territories linked to it (OCTs))
  • Eligible non-EU countries : listed EEA countries and countries associated to the EU4Health Programme or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before the deadline for submission

Content reserved for subscribers

Register for free to access the content

Free access to all information

Priorities and funded actions

Objective

To develop early warning mechanisms and guidance in the area of pricing through the EURIPID database, based on lessons from competition cases, in particular on excessive pricing.

Priorities

  • Priority 1: create common approaches to verify claims on price information and to provide appropriate guidance to adjust pricing methodologies.
  • Priority 2: prevent price increases based on unfounded claims to recover investments and increased costs.

Among financed actions

Monitoring of strategic sequencing of price increases of threats to de-list reimbursable medicines or withdraw of medicines.

Additional information 

  • This call for proposals is an open call for proposals
  • Initial duration of the action: between 12 and 36 months

Eligibility

  • Be legal entities (public or private bodies)
  • Be established in one of the eligible countries
  • A consortium composed of at least 6 eligible applicants established in at least 5 different eligible countries.
Financement
  • Total amount of the call: 107,3 million euro
  • Total budget of the topic “Develop early warning features and guidance in the area of pricing through the EURIPID database, based on competition cases“: 300,000 euro
  • Amount of the grant : up to 300,000 euro – one single proposal
  • Co-financing rate: up to 60% of the total eligible costs; or up to 80% if your project is of “exceptional utility”

Test your eligibility

Other funds:

Aucune relation trouvée.

Similar news

14 February 2022

€1.3 billion for HERA first work plan – a step towards the European Health Union

Lire l'aticle

22 October 2021

€650 million investment to accelerate French digital health strategy

Lire l'aticle